🔎 Trials Near Me

Domov › Srpkovitá anémie › Illinois › Chicago

Klinické štúdie Srpkovitá anémie v meste Chicago, IL

18 štúdií pre Srpkovitá anémie hľadá účastníkov v zariadeniach v meste Chicago a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease

Prebieha náborFáza 1
  • University of Illinois at Chicago College of Medicine, Chicago
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT04055818

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Prebieha náborFáza 3
  • Uni of Illinois Hospital and HSC, Chicago
Vek 12 až 100 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Prebieha náborFáza 1
  • University of Illinois Hospital and Health Sciences System, Chicago
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Prebieha náborFáza 3
  • Univer Of Illinois at Chicago, Chicago
Vek 2 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Prebieha náborFáza 3
  • Childrens Hospital of Chicago, Chicago
  • Univer Of Illinois at Chicago, Chicago
Vek 12 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06612268

Tocilizumab for Acute Chest Syndrome

Prebieha náborFáza 2
  • University of Chicago, Chicago
Vek 12 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT05640271

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
  • Local Institution - 0034, Chicago
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

Prebieha náborFáza 2/3
  • University of Illinois at Chicago Clinical Research Center, Chicago
  • University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
  • University of Illinois Hospital and Health Sciences System, Chicago
Vek 12 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Prebieha náborObservačná štúdia
  • Rush University Medical Center, Chicago
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Prebieha náborFáza 2
  • University of Illinois at Chicago, Chicago
Vek 12 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Prebieha náborFáza 3
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Vek 10 až 65 · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT06975865

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Prebieha náborFáza 2
  • University of Illinois at Chicago, Chicago
Vek 16 až 60 · Všetky pohlavia · Aktualizované 8. 7. 2026 · NCT03121001

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Prebieha náborObservačná štúdia
  • Comer Children's Hospital (MRD-HCT), Chicago
Vek 3 až 20 · Všetky pohlavia · Aktualizované 4. 6. 2026 · NCT06941389

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

Prebieha náborFáza 2
  • University of Illinois Chicago, Sickle Cell Center, Chicago
Vek 18 až 60 · Všetky pohlavia · Aktualizované 19. 5. 2026 · NCT07175051

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

Prebieha nábor
  • University of Illinois at Chicago, Chicago
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 3. 2026 · NCT06919224

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Prebieha náborFáza 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Vek 2 až 25 · Všetky pohlavia · Aktualizované 10. 3. 2026 · NCT03587272

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Prebieha nábor
  • Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Vek 16 až 30 · Všetky pohlavia · Aktualizované 7. 1. 2026 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Prebieha náborObservačná štúdia
  • University of Illinois, Chicago
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 6. 2025 · NCT06385886

Štúdie Srpkovitá anémie v iných mestách

Iné štúdie v Chicago

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.